Welcome to our dedicated page for Sabra Health Care Reit SEC filings (Ticker: SBRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sabra Health Care REIT, Inc. (SBRA) SEC filings page on Stock Titan brings together the company’s regulatory disclosures as a Maryland-incorporated, self-administered, self-managed healthcare REIT listed on The Nasdaq Stock Market LLC. Through these filings, investors can review how Sabra reports its financial results, portfolio activity, capital structure decisions and other material events related to its healthcare real estate business in the United States and Canada.
Sabra’s Form 8-K filings frequently cover quarterly earnings releases, where the company presents net income alongside non-GAAP measures such as funds from operations (FFO), Normalized FFO, Adjusted FFO (AFFO), Normalized AFFO, net operating income (NOI), Cash NOI and Net Debt to Adjusted EBITDA. These filings often reference supplemental information packages and reconciliations of non-GAAP financial measures that explain how the metrics relate to GAAP results and how they reflect performance across skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities and specialty hospitals and other properties.
Other 8-K filings document capital markets transactions and financing activities, including equity distribution agreements supporting at-the-market equity offering programs, forward sale agreements for common stock, new term loans and the redemption of outstanding senior notes. These disclosures outline how Sabra raises capital, refinances debt and funds investments in its healthcare real estate portfolio.
On this page, Stock Titan provides real-time access to Sabra’s filings as they appear on EDGAR, along with AI-powered summaries that help explain key points from lengthy documents such as earnings-related 8-Ks and accompanying exhibits. Users can quickly locate quarterly and annual reports, review material definitive agreements, track changes in capital structure and understand the regulatory context around Sabra’s operations as a healthcare-focused REIT.
Sabra Health Care REIT Inc ownership disclosure: Vanguard Capital Management reports 13,315,431 shares of Common Stock, representing 5.28% of the class as of the filing. The filer states sole dispositive power over 13,315,431 shares and sole voting power over 2,084,683 shares. The disclosure lists affiliated Vanguard entities and notes holdings include securities held for Vanguard funds and managed accounts.
Sabra Health Care REIT reported higher first‑quarter results with total revenues of $221.8 million for the three months ended March 31, 2026, up from $183.5 million a year earlier, driven mainly by its Senior Housing - Managed portfolio.
Net income attributable to Sabra was $40.9 million, slightly above $40.3 million last year, with diluted earnings per share of $0.16. Operating cash flow rose to $98.4 million from $80.3 million, while the company invested $96.1 million to acquire three Senior Housing - Managed communities and one skilled nursing/transitional care facility.
As of March 31, 2026, Sabra owned 361 properties plus joint venture interests, with real estate investments, net, of $4.70 billion and total assets of $5.59 billion. Total debt was $2.69 billion, including a $355.0 million revolving credit facility balance and $1.25 billion of senior unsecured notes. The board declared a quarterly cash dividend of $0.30 per share.
Sabra Health Care REIT reported solid first quarter 2026 results and reiterated its full-year guidance. Net income attributable to common shareholders was $40.9 million, or $0.16 per diluted share. Key REIT metrics were stronger, with FFO of $0.37 and AFFO and Normalized AFFO of $0.39 per diluted share.
Same property managed senior housing Cash NOI rose 14.4% year over year, reflecting improving operating performance. Sabra invested $102.0 million in the quarter and $206.1 million year to date in senior housing and skilled nursing assets at an estimated initial cash yield of about 8.0%, and has been awarded an additional $200 million of higher-yielding opportunities.
Liquidity remained robust at approximately $1.2 billion as of March 31, 2026, including $116.5 million of cash, sizeable revolver capacity, and forward equity proceeds, while Net Debt to Adjusted EBITDA stood at 5.04x. The board declared a quarterly dividend of $0.30 per common share.
Sabra Health Care REIT Inc ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 23,239,071 shares of Common Stock, representing 9.21% of the class as of 03/31/2026. The filing states this position reflects holdings across Vanguard affiliates and funds, "In accordance with SEC Release No. 34-39538 (January 12, 1998)".
Sabra Health Care REIT, Inc. has issued its 2026 proxy statement for the annual stockholder meeting on June 17, 2026 at its Tustin, California headquarters. Stockholders of record on April 14, 2026 may vote in person or by Internet, phone or mail.
Key items include electing directors, ratifying PwC as independent auditor for the year ending December 31, 2026, and a non-binding advisory vote on named executive officer compensation. The board is majority independent, uses majority voting for uncontested elections, provides proxy access, has no stockholder rights plan and has opted out of certain Maryland takeover defenses.
Executive pay is heavily performance-based, with about 65% of 2025 equity grant value in relative total stockholder return units, a five-year deferral and one-year post-vesting holding period, plus stringent stock ownership requirements of 10x base salary for the CEO and 5x for other executives. The proxy also highlights sustainability reporting, board and workforce diversity and formal oversight of human capital and ESG matters.
Sabra Health Care REIT Inc received an Schedule 13G/A (Amendment No. 15) from The Vanguard Group that reports zero beneficial ownership of its Common Stock. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 and is signed on 03/27/2026.
The filing lists Amount beneficially owned: 0 and Percent of class: 0%, with all voting and dispositive powers shown as 0.
Sabra Health Care REIT, Inc. Executive VP & CAO Jessica Flores reported an open-market sale of 15,231 shares of common stock on March 25, 2026 at a weighted average price of $19.86 per share, with individual trades ranging from $19.85 to $19.89.
After this transaction, she directly holds 71,709 shares, which include 25,527 stock units that will settle on a one-for-one basis in Sabra common stock.
Sabra Health Care REIT, Inc. director Jeffrey A. Malehorn reported an automatic acquisition of 781 common stock units on February 27, 2026. These units were credited as dividend-equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carried no purchase price.
After this transaction, Malehorn directly holds 107,219 common stock units, including 2,854 unvested units and 51,345 units that have vested but with payment deferred. Each stock unit represents the right to receive one share of Sabra’s common stock, following the original grant’s vesting and payment terms.
Sabra Health Care REIT, Inc. director Ann Kono reported an acquisition of 781 shares of common stock on a Form 4. These were stock units credited as dividend-equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan, at a price of $0 per unit.
After this grant, she holds a total of 59,059 stock units, including 2,854 unvested units and 51,345 units that have vested but whose payment has been deferred. Each stock unit represents the right to receive one share of Sabra’s common stock.